A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Recruiting now · Phase 1/Phase 2
Conditions studied: Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, Rheumatoid Arthritis
In brief
This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.
Key facts
- Study ID
- NCT06733935
- Run by
- Nkarta, Inc.
- People needed
- 240
- Starts
- 2024-11-04
- Expected to finish
- 2028-10-01
- Last updated by the study team
- 2026-08-07
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Nkarta Investigational Site — Manati, Puerto Rico (enrolling)
- Nkarta Investigational Site — Gainesville, Florida, United States (enrolling)
- Nkarta Investigational Site — Orange, California, United States (enrolling)
- Nkarta Investigational Site — Plantation, Florida, United States (enrolling)
- Nkarta Investigational Site — Chicago, Illinois, United States (enrolling)
- Nkarta Investigational Site — Fairway, Kansas, United States (enrolling)
- Nkarta Investigational Site — Ann Arbor, Michigan, United States (enrolling)
- Nkarta Investigational Site — Minneapolis, Minnesota, United States (enrolling)
- Nkarta Investigational Site — Hackensack, New Jersey, United States (enrolling)
- Nkarta Investigational Site — Summit, New Jersey, United States (enrolling)
- Nkarta Investigational Site — New York, New York, United States (enrolling)
- Nkarta Investigational Site — Stony Brook, New York, United States (enrolling)
- Nkarta Investigational Site — Syracuse, New York, United States (enrolling)
- Nkarta Investigational Site — Charlotte, North Carolina, United States (enrolling)
- Nkarta Investigational Site — Dallas, Texas, United States (enrolling)
- Nkarta Investigational Site — Houston, Texas, United States (enrolling)
- Nkarta Investigational Site — Melbourne, Victoria, Australia (enrolling)
- Nkarta Investigational Site — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.